ArticleCell death & disease2022

Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a DDB2-mediated mechanism.

Trace M Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.